Question.1825 - https://www.youtube.com/watch?v=-2BzLKGx_nghttps://www.youtube.com/watch?v=mZWGzWPqja0
Answer Below:
Breast xxxx Cancer xxxx Screening xxxxxxxxx is xxx process xx examining x woman's xxxxxxx for xxxxxx before xxx onset xx any xxxxxxxx Mammography xxx ultrasound xxxxxxxxxxxx tomosynthesis xxxxxx sample xxx biopsy xxxxxxxx digital xxxx and xxxxxxxxxxxx exam xxx only xxx of xxx procedures xxxx to xxxx for xxxxxx cancer xxxxx should xx able xx have xx in-depth xxxxxxxxxxxx with xxxxx main xxxxxxxxxx practitioner xxx have xxxxxxxxxxx involvement xxxx the xxxxxxxx choice xx which xxxxxxxxx technique xx best xxx them xxxxxxxx and xxxxxxxxxxxxx decision-making xxxxxxxxx this xxxxxxx Among xxxxxxx in xxxxx America xxxxxx cancer xx the xxxxxx highest xxxxx of xxxxxxxxx Breast xxxxxx affects xx women xxx claims xxx lives xx in xxxx Therefore xx Advanced xxxxxxxx Nurses xxxx we xxxx a xxxxxxxxxxxxxx to xxxxxx to xxx guidelines xxxxxxxxxxx by xxxxxxxxxxxxx such xx the x S xxxxxxxxxx Services xxxx Force xxxxxx the xxxxxxx of xxxxxxxxxxxxx and xxxxxxxxxxxxxx ACOG xxx American xxxxxx Society xxx the xxxxxxxx Cancer xxxxxxxxx NCI xxx Susan x Komen xx name x few xxxxxxx nbsp xxxxxxxxxxxxx nbsp xxx nbsp xxxxxx nbsp xxxxxx nbsp xxxxxxxxx Screening xxx breast xxxxxx is x great xxx to xxxxxxxx and xxxxx the xxxxxxx before xxx symptoms xxxxxx To xxx it xxxxxx screenings xxxx lives xx order xx provide xxx best xxxx possible xxx my xxxxxx cancer xxxxxxxxx patients x will xxxxxx that xxx women xxx visit xx clinic xxxxxx to xxx guidelines xxxxxxxxxxx by xxx United xxxxxx Preventive xxxxxxxx Task xxxxx USPTF xxxxxxxx et xx Therefore xxxxx two xxxxx women xxxx - xxxx have x mammography xxxxx to xxxxxxxxxx any xxxxx the xxxxxxxxxxx and xxxxxxxxxx benefits xxx drawbacks xx women xxxxx the xxx of xxxx be xxxxx into xxxxxxx Patients xxx continue xx get xxxxxxx if xxxx are xx years xxx and xxxx it xxxxx benefit xxxxx health xxx if xxxx don't xxxxx screening xx worthwhile xxxx don't xxxx to xxxxxxx it xxxxxxxxx amp xxx There xx not xxxxxx evidence xx suggest xxxxxx disease xxxx screening xx thought xx be xxxxxxx beyond xxx Screening xxx prevent xxxxxx from xxxxxxxxxxx and xxxx most xxxxxx for xxxxx between xxx ages xx and xxxxxxx in xxx age xxxxxxx of xxxxx false xxxxxxxx and xxxxx negative xxxxxxxx may xxxxx owing xx factors xxxx the xxxxxxx of xxxxxx issues xxxxxxx to xxxxxxxx testing xxxxx costs xxx patient xxxx money xxxxxxxxxxxxxx and xxxxxxxxx conditions xxx also x result xxxxxx Early xxxxxxxxxx are xxx necessary xxxxx a xxxxxx history xx cancer xx atypical xxxxxx are xxxxxxxx making xxx advantages xx screening xx this xxx totally xxxxxxxxx on xxxxxxx desire xxxxxxxxx those xxxxxxx the xxxx of xxx yields xxxx advantages xxxx those xxxxxxx the xxxx of xxx Miller xxxxxx than xxxxxxx only xx patients' xxxxxxx of xxxxxxxxx completion x would xx a xxxxxx check xx verify xxxx all xxxxxxxxx screenings xxx women xxxx to xxx been xxxxxxxxx Interventions xxxxxx nbsp xxxxxxxxx nbsp xxxxxxx When x get x patient's xxxxxxxxxxx report xxxx the xxxxx year xxx examine xxx patient's xxxx to xxxxxx the xxxxxxxx accuracy x will xxxxxxx the xxx sets xx data xxxxxxxxxxxxx amp xxxxxxxxxx The xxxxxxxxxx of xxxxxxxx who xxxxxxxx have xxxxxxxxx mammography xx expected xx rise xxxxxxxxxxxx if xxxxxxxxxx take xx active xxxx in xxx process xx observing xxxxxxxxxx tracking xxxxxxxx and xxxxxxxx out xx those xxx are xxxxxx to xxxxxx in xxxxx to xxxxxx understand xxx hurdles xxxx face xxx how xx remove xxxx Educate xxxx with xxxx Pamphlets xx a xxxxxxx does xxx fully xxxxx the xxxx of xxxxxxx a xxxxxxxxx I xxxx give xxxx the xxxxxxxxxx along xxxx the xxxxxxxxxxx prescription xxx urge xxxx to xxx questions xxxxxxx my xxxxxxxxxxxx I xxxx evaluate xxx many xxxxxx took xxx screening xxxx before xxx how xxxx people xxxx the xxxx after xxxxxxxxx the xxxxxxx This xxxxx mean xxxx patients xxx more xxxx to xxxxx tested xxx that xxxx have x deeper xxxxxxxxxxxxx of xxx process xxx are xxxxxxxx for xxxx in-depth xxxxxxxxxxx Saulsberry xx al xxxx will xxxx like xxxx have x voice xx the xxxxxxx which xxxxxx their xxxxxxxxxx to xxxxxx through xxxx the xxxxxxxxx plan xxxx a xxxxxxxxxxxxx method xx caring xxx and xxxxxxxxxxxxx with xxxxxxxx Obtain xxxx Family xxxxxxx In xxxxx to xxxxxxx the xxxx appropriate xxxxxxxxx for xxxx individual xxxxxxx it xx crucial xx have x complete xxxxxxx of xxxxx family xxxxxxx Choosing x screening xxxxxxxxx or xxxxxxxxx programme xxx be xxxxxxx for xxxxxxxx for x patient xxxx breast xxxxxx who xxx a xxxxxx history xx relatives xxx have xxxx treated xxx being xxxxxxx or xxxx died xxxx the xxxxxxx A xxxxxx frequency xx breast xxxxxx screenings xx genetic xxxxxxx may xx necessary xxx patients xxxx a xxxxxx history xx the xxxxxxx ACOG xxxxxxxx at xxxx risk xxx getting xxxxxx cancer xxxx BRCA xxxxx syndrome xxxx be xxxxxxxxxx with xxxx test xxxxxxxxx monitoring xx these xxxxxx has xxx potential xx discover xxxxxx cancer xxxxx allowing xxx more xxxxxxxxx treatment xxx a xxxxxxxx recovery xxxxxx cancer xxx be xxxxxx by xxxxxxxxx in xxx BRCA xx BRCA xxxxx cancers xx the xxxxxxxxxxxxxxxx tract xxx pancreas xxx be xxxxxx by xxxxxxxxx in xxx Lynch xxxxxxxx gene xxx so xx Ghoncheh xx al xxxxxxxx rates xxx be xxxxxxxxx with xxxxx diagnosis xxx focused xxxxxxx thanks xx genetic xxxxxxx and xxxxxxx monitoring xxx survival xxxxxxxxxx may xx greatly xxxxxxxxx with xxxxx diagnosis xxxxxxxxxx We xxxx able xx find xxxxxxxxxxx with xxxxxxxx results xx screening xxxx for xxxxxx cancer xxxxxxxxx to xxxxx screening xxxxxxxxxx Patients xxxx genetic xxxxxxxxx and xxxxx with x family xxxxxxx of xxx disorder xxxxxxx further xxxxxxx in xx effort xx identify xxx underlying xxxxxxx cause xxxxxxx checks xxxxx for xxxxxx treatment xxx a xxxxxx chance xx survival xx facilitating xxxxx patient xxxxxxxxx By xxxxxxxxx the xxxxxxx in xxxxxx we xxx be xxxx that xxx patients xxx actually xxxxxxxxx our xxxxxxxxxxxxxxx and xxxxxxxxxx mammograms xx distributing xxxxxxxx and xxxxxxxx patients xxxxxxx in xxxxxxxxxxxxx about xxxxxxxxx tests xxx by xxxxxxxxxx a xxxxxxxx family xxxxxxx that xxxx help xxxxxx future xxxx Screening xxxxxxxxxxxxx rates xxx be xxxxxx and xxxxxx cancer xxxxxxxxx rates xxxxxxx through xxxxxxxxxxx and xxxxxxxxxx effective xxxxxxxxx that xxx customized xx each xxxxxxxxx requirements xxxxxxxxxxxx treating xxx patients xxxxxxxx their xxxxxxx of xxxx and xxxxx them xxx well xxxxxx nbsp xxxx References xxxx ACOG xxxxxx cancer xxxx assessment xxx screening xx average-risk xxxxx https xxx acog xxx clinical xxxxxxxxxxxxxxxxx practice-bulletin xxxxxxxx breast-cancer-risk-assessment-and-screening-in-average-risk-womenGhoncheh x Pournamdar x amp xxxxxxxxxx H xxxxxxxxx and xxxxxxxxx and xxxxxxxxxxxx of xxxxxx cancer xx the xxxxx Asian xxxxxxx Journal xx Cancer xxxxxxxxxx sup xxxxx https xxx org xxxxx s xxxxxxxxx M x amp xxx J x Awareness xx the xx Preventive xxxxxxxx Task xxxxx recommended xxxxxxx in xxxxxxxxxxx screening xxxxxxxxxx accuracy xx awareness xxxxxxx of xxxxxxxxx about xxxxxxxxxxxxxxx and xxxxxxxxx about xxxxxxx screening xxxxxxxxxx in xxxxx ages xxxxx and xxx Public xxxxxx https xxx org x - x Miller x An xxxxxxxxxx approach xx worker xxxxxxxxxxxxxxx and xxxxxx outcomes xxxxxxx conditions xxxxxxxxxxxxxx practice xxx Health xxxxxxxx AAOHN xxxxxxx ndash xxxxx doi xxx - x Momenimovahed x amp xxxxxxxxxx H xx P xx epidemiological xxxxxxxxxxxxxxx of xxx risk xxxxxxx for xxxxxx cancer xx the xxxxx lt x gt xxxxxx Cancer xxxxxxx and xxxxxxx Volume xxxxx https xxx org xxxx s xxxxxxxxxx L xxxx L x amp xxxxxxx N x The xxxxxx of xxxxxx density xxxxxxxxxxxx laws xx supplemental xxxxxx imaging xxx breast xxxxxx Journal xx General xxxxxxxx Medicine xxxxx https xxx org x - x - xxxxMore Articles From Biology
.ico)
.ico)
.ico)
.ico)
